Ipsos: Disclosure Of Trading In Own Shares Under A Share Buyback Programme (9 To 13 November 2026)


Date:

(MENAFN- GlobeNewsWire - Nasdaq) 17 November 2026

Disclosure of trading in own shares

under a share buyback program

Period: From 9 to 13 November 2026

Issuer's registered name: Ipsos

Issuer's Identification code: 9695002OY2X35E9X8W87

Financial instrument reference: Ordinary shares – ISIN code FR0000073298

Reporting of transactions in aggregated form (per day and per trading venue)

Issuer name Issuer Code Transaction date ISIN Code Daily total volume (in number of shares) Daily weighted average price of shares acquired Platform
ISIN code (ISO 6166) MIC code (ISO 10383)
IPSOS 9695002OY2X35E9X8W87 9-Nov-26 FR0000073298 10 257 35,9333 XPAR
IPSOS 9695002OY2X35E9X8W87 9-Nov-26 FR0000073298 6 451 35,8724 CEUX
IPSOS 9695002OY2X35E9X8W87 10-Nov-26 FR0000073298 11 626 36,1022 XPAR
IPSOS 9695002OY2X35E9X8W87 10-Nov-26 FR0000073298 4 929 36,0873 CEUX
IPSOS 9695002OY2X35E9X8W87 11-Nov-26 FR0000073298 10 919 35,8414 XPAR
IPSOS 9695002OY2X35E9X8W87 11-Nov-26 FR0000073298 5 781 35,7459 CEUX
IPSOS 9695002OY2X35E9X8W87 12-Nov-26 FR0000073298 11 812 36,1203 XPAR
IPSOS 9695002OY2X35E9X8W87 12-Nov-26 FR0000073298 4 738 36,0819 CEUX
IPSOS 9695002OY2X35E9X8W87 13-Nov-26 FR0000073298 9 621 36,1260 XPAR
IPSOS 9695002OY2X35E9X8W87 13-Nov-26 FR0000073298 6 966 35,9477 CEUX

Detailed presentation by transaction

A detailed presentation by transaction is available on the Company's website ( ), in the section on regulated information, in the chapter entitled:“Share buyback programs and share buyback declarations”:

Attachment

  • target="_blank" href="" title="2026 11 17_Communiqué_Rachat d'actions propres_va" rel="nofollow">2026 11 17_Communiqué_Rachat d'actions propres_v

MENAFN17112026004107003653ID1111977664


GlobeNewsWire - Nasdaq

Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.



More Story

Search